A progressive and cell non-autonomous increase in striatal neural stem cells in the Huntington's disease R6/2 mouse

被引:43
|
作者
Batista, Claudia M. C.
Kippin, Tod E.
Willaime-Morawek, Sandrine
Shimabukuro, Marilia Kimie
Akamatsu, Wado
van der Kooy, Derek
机构
[1] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Histol & Embryol, BR-21941590 Rio De Janeiro, Brazil
[2] Univ Toronto, Dept Med Genet & Microbiol, Neurobiol Res Grp, Toronto, ON M5S 3E1, Canada
[3] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA
来源
JOURNAL OF NEUROSCIENCE | 2006年 / 26卷 / 41期
关键词
neural stem cells; progenitor cells; Huntington's disease; subependyma; migration; R/2; mice;
D O I
10.1523/JNEUROSCI.2850-06.2006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neural stem and progenitor cells are located in the subependyma of the adult forebrain. An increase in adult subependymal cell proliferation is reported after various kinds of brain injury. We demonstrate an expansion of neural precursor cells in the postnatal subependyma in a murine genetic disease model of Huntington's disease (HD), the R6/2 mouse. We used the in vitro neurosphere assay as an index of the number of neural stem cells in vivo and to assess proliferation kinetics in vitro and in vivo bromodeoxyuridine labeling to assess the progenitor cell population and their fates. Disease progression in this model leads to an increase in the numbers of neural stem cells in the adult striatal subependyma. This increase is produced cell non-autonomously by events in the R6/2 brains as the mice become increasingly symptomatic. Once the neural stem cell increase is induced in vivo, it is maintained during in vitro passaging of neural stem cells, but the neural stem cell increase is not reproduced during in vitro passaging of neural stem cells from presymptomatic R6/2 mice. In addition, we show that some of the R6/2 neural progenitor cells show a change from their normal migration destiny toward the olfactory bulb. Instead, some of these cells migrate into the striatum, one of the main affected areas in HD. Our findings demonstrate that HD damage recruits precursor cells in two ways: expansion of neural stem cells and altered migration of progenitor cells.
引用
收藏
页码:10452 / 10460
页数:9
相关论文
共 50 条
  • [1] Progressive Mitochondrial Dysfunction of Striatal Synapses in R6/2 Mouse Model of Huntington's Disease
    Petersen, Maria Hvidberg
    Willert, Cecilie Wennemoes
    Andersen, Jens Velde
    Madsen, Mette
    Waagepetersen, Helle Sonderby
    Skotte, Niels Henning
    Norremolle, Anne
    JOURNAL OF HUNTINGTONS DISEASE, 2022, 11 (02) : 121 - 140
  • [2] Treatment Efficacy of Transplanted Human Striatal Neural Stem/Progenitor Cells in the R6/2 Mouse Model of Huntington's Disease
    El-Akabawy, G.
    Rattray, I.
    Solanky, B.
    Gale, R.
    Bates, G.
    Modo, M.
    CELL TRANSPLANTATION, 2010, 19 (03) : 338 - 338
  • [3] RETINAL AND STRIATAL PROFILING OF THE R6/1 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Valor, Luis M.
    Gallardo-Orihuela, Andrea
    Cano-Cano, Fatima
    Gomez-Jaramillo, Laura
    Hervas-Corpion, Irati
    Martin-Loro, Francisco
    de la Villa, Pedro
    Arroba, Ana I.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 : A6 - A6
  • [4] Striatal oligodendrogliogenesis and neuroblast recruitment are increased in the R6/2 mouse model of Huntington's disease
    McCollum, Mark H.
    Leon, Rebecca T.
    Rush, Daniel B.
    Guthrie, Kathleen M.
    Wei, Jianning
    BRAIN RESEARCH, 2013, 1518 : 91 - 103
  • [5] Hair dysmorphology in the R6/1 and R6/2 mouse models of Huntington's disease
    Pierzynowska, Karolina
    Podlacha, Magdalena
    Luszczek, Dorota
    Rintz, Estera
    Gaffke, Lidia
    Szczudlo, Zuzanna
    Tomczyk, Marta
    Smolenski, Ryszard T.
    Wegrzyn, Grzegorz
    GENE, 2021, 765
  • [6] Striatal Pre-Enkephalin Overexpression Improves Huntington's Disease Symptoms in the R6/2 Mouse Model of Huntington's Disease
    Bissonnette, Stephanie
    Vaillancourt, Mylene
    Hebert, Sebastien S.
    Drolet, Guy
    Samadi, Pershia
    PLOS ONE, 2013, 8 (09):
  • [7] LAQUINIMOD IN THE R6/2 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Ellrichmann, Gisa
    Blusch, Alina
    Fatoba, Oluwaseun
    Brunner, Janine
    Pitarokoili, Kalliopi
    Hayardeny, Liat
    Saft, Carsten
    Gold, Ralf
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A92 - A92
  • [8] Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease
    Valenza, Marta
    Leoni, Valerio
    Tarditi, Alessia
    Mariotti, Caterina
    Bjorkhem, Ingernan
    Di Donato, Stefano
    Cattaneo, Elena
    NEUROBIOLOGY OF DISEASE, 2007, 28 (01) : 133 - 142
  • [9] Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model
    Choo, YS
    Mao, ZK
    Johnson, GVW
    Lesort, M
    NEUROSCIENCE LETTERS, 2005, 386 (01) : 63 - 68
  • [10] Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease
    Traficante, Anna
    Riozzi, Barbara
    Cannella, Milena
    Rampello, Liborio
    Squitieri, Ferdinando
    Battaglia, Giuseppe
    NEUROREPORT, 2007, 18 (18) : 1997 - 2000